← Eichor
Study identifier: NCT06831565 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy

Condition: Acute-On-Chronic Liver Failure  ·  Sponsor: Institute of Liver and Biliary Sciences, India

PhaseNA
Planned participants790
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Coagulation system in cirrhotics patients is a fragile state , which is rebalanced hemostasis. Standard tests (INR/aPTT) stop measuring at first stage of coagulation ,when the clot first form. VETs measure the whole process such as ROTEM, TEG and comparing these two tests to assess for transfusion of blood products for invasive procedures. . ROTEM provides information both on anti coagulant and procoagulant status where as conventional tests provide only anti coagulant status Invasive procedures can be low risk or high risk or Non surgical vs surgical, Procedure related bleed occurs in 7% of patients with cirrhosis and associated with higher 28 day mortality. MELD, CTP ,AKI , SEPSIS increase the risk of procedure related bleed. Hence for invasive procedures investigator is using relaxing threshold for blood product transfusion in cirrhosis, ACLF patients. As use of ROTEM when compared to conventional tests reduces the need for blood transfusion. Investigator want to proceed with further relaxation of cutoff values of Coagulation parameters and use High cutoff vs low cut off for blood transfusion need.

This description comes directly from the study's public registry record.

Talk to the study team

Dr Sanda Kavitha, MD  ·  01146300000  ·  sandakavitha1001@gmail.com

Dr Manoj Kumar Sharma, DM  ·  01146300000  ·  manojkumardm@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Institute of Liver & Biliary Sciences (ILBS)New Delhi, National Capital Territory of Delhi, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06831565